Outcome of Trabeculectomy in Sokoto: Glaucoma

Dantani Adamu Mohammed; Muhammad Nasiru

Authors

Dantani Adamu Mohammed Ophthalmology department, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria
Muhammad Nasiru Ophthalmology department, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria

Abstract

Introduction: Glaucoma is the second leading cause of blindness worldwide1 and the leading cause of irreversible blindness accounting for 6.6% of 39 million global burden of blindness2 . Trabeculectomy is said to be better than both medical and laser therapies in IOP control especially among Africans where compliance and availability of drugs are limited3-5. The aim of this study was to assess the outcome of trabeculectomy in patients diagnosed with glaucoma between May 2008 and December 2015 in Usmanu Danfodiyo University Teaching Hospital, Sokoto and Specialist Hospital, Sokoto.

Methods: This was a retrospective case series. The medical records of all glaucoma patients who had trabeculectomy between May 2008 and December 2015 in the two facilities were reviewed. Demographic and clinical data were retrieved. All glaucoma patients aged 9 years and above who had trabeculectomy or combined glaucomacataract surgery were eligible for inclusion in the study. Ethical approval was obtained from the Ethics and Research Committee of the Usmanu Danfodiyo University Teaching Hospital, Sokoto. All patients had a Cairns-type trabeculectomy. 6 Some surgeries were performed with the use of antimetabolites- Mitomycin C (MMC) or 5 Fluorouracil (5FU) based on availability of the antimetabolites at the time of surgery. Two surgeons performed all the surgeries. The primary outcome measure was percent IOP reduction from baseline during the post-operative period. Data was analysed using Stata 14 statistical software.

Views | Downloads: 26 / 12

References

Foster A, Resnikoff S. The Impact of vision 2020 on global blindness. Eye (Lond) 2005; 19:1133-1135

Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmology. 2015;15(1):111.

Lichter PR, Musch DC, Gillespie BW, Gurie KE, Janz NK, Wren PA, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108:1943-1953

AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment group. Am J Ophthalmol 2001; 132: 311- 320

Kabiru J, Bowman R, Wood M, Mafwiri M. Audit of trabeculectomy at a tertiary referral hospital in East Africa. J Glaucoma 2005; 14:432-434

Cairns JE. Trabeculectomy: preliminary report of a new technique. Am J Ophthalmol 1968; 66: 673-679

Adegbehingbe BO, Majemgbasan T. A review of trabeculectomies at a Nigerian teaching hospital. Ghana Med J 2007; 41:176-180

Mielke C, Dawda VK, Anand N. Intraoperative 5-fluorouracil application during primary trabeculectomy in Nigeria: a comparative study. Eye. 2003; 17(7): 829- 834

Bekibele CO. Evaluation of 56 trabeculectomy operations at Ago-Iwoye, Ogun state, Nigeria. West Afr J Med 2001; 20(3): 223-226

Olawoye OO, Ashaye AO, Baiyeroju MA, Teng CC et al. Outcomes of trabeculectomy with 5-Fluorouracil at a Nigerian Tertiary Hospital. J Ophthalmic Vis Res 2013; 8(2):126-133

Ashaye AO, Komolafe OO. Post-operative complication of trabeculectomy in Ibadan, Nigeria: outcome of one-year follow-up. Eye (Lond) 2009; 23: 448-452

Naveh N, Kottas R, Glovinsky J, Blumenthal M, et al. The long-term effect on intraocular pressure of a procedure combining trabeculectomy and cataract surgery, as compared with trabeculectomy alone. Ophthalmic Surgery, Lasers and Imaging Retina 1990; 21(5): 339-345

Friedman DS, Jampel HD, Lubomski LH, et al. Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology 2002;109:1902- 1913